Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elagolix in moderate or severe endometriosis-associated pain
NCT06076486Phase 3Completed
- Sponsor
- Nanjing Chia-Tai Tianqing Pharmaceutical
- Start
- Sep 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of elagolix in endometriosis, sponsored by Nanjing Chia-Tai Tianqing Pharmaceutical. Started Sep 2023; status: completed.
02
Drugs
elagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT06076486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06076486.